BME Professor Aijun Wang Wins $3.1M CIRM Grant

A research team from UC Davis Biomedical Engineering has recently been awarded a $3.1 million, two-year grant from the California Institute for Regenerative Medicine (CIRM) for an innovative medical device that could improve treatment outcomes and the quality of life for the more than two million people throughout the world who are on hemodialysis.

UC Davis' Alyssa Panitch Develops Protective Therapies for Osteoarthritis and Vascular Conditions

UC Davis biomedical engineering (BME) professor Alyssa Panitch seeks to prevent our bodies from getting in their own way when we’re healing wounds. Inflammation has its place and protects us from many disease-causing organisms and helps with tissue healing. However, too much inflammation and scar tissue can also contribute to serious health problems.

Quarter at Aggie Square: Innovation Hub Kicks Off With Undergraduate Courses

Eleven third-year biomedical engineering UC Davis students were welcomed into the inaugural Biomedical Engineering in Sacramento experience offered through the Quarter at Aggie Square (QAS) Program this fall by Diana Farmer, chair of the surgery department, and Allison Brashear, Dean of the School of Medicine, two of the champions of the collaboration with UC Davis, Aggie Square and the Medical Center. The QAS program is an immersive academic experience program that brings UC Davis undergraduate students to Sacramento to benefit from learning at the health campus and surrounding area.

Marcu Lab Receives Grant From National Heart, Lung and Blood Institute for Interventional Cardiology

Research in Laura Marcu’s laboratory promotes better diagnosis, treatment, and prevention of human diseases through advancements in biophotonics technology – a field at the interface of physical sciences, engineering, biology, and medicine.  

They have received their third National Institutes for Health grant for continuing work on the clinical applications of fluorescent lifetime imaging (FLIm) for diagnostic and surgical purposes.  

Biomedical Engineering Professor Cheemeng Tan Receives NIH Grant to Engineer Synthetic Bacteria for Translational Clinical Medicine

Unlike the dinosaurs in Jurassic Park, the synthetic bacteria in Cheemeng Tan’s lab will not find a way to replicate. As he explains, ‘We will modify our synthetic bacteria using a method that turns them into controllable living micromachines.’ That means clinicians will be able to administer them in a controlled way for medical applications, including delivering medicine within the body, CRISPR-Cas gene editing, killing cancer cells, and administering probiotics and oral vaccines.